Change in Metabolic Syndrome Parameters With Antipsychotic Treatment in the CATIE Schizophrenia Trial: Prospective Data From Phase 1

BACKGROUND: The metabolic syndrome (MS) is associated with increased risk for diabetes mellitus and coronary heart disease, and is highly prevalent among schizophrenia patients. Given concerns over antipsychotic metabolic effects, this analysis explored MS status and outcomes in phase 1 of the CATIE...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Meyer, Jonathan M., Davis, Vicki G., Goff, Donald C., McEvoy, Joseph P., Nasrallah, Henry A., Davis, Sonia M., Rosenheck, Robert A., Daumit, Gail L., Hsiao, John, Swartz, Marvin S., Stroup, T. Scott, Lieberman, Jeffrey A.
Формат: Artigo
Язык:Inglês
Опубликовано: 2008
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3673564/
https://ncbi.nlm.nih.gov/pubmed/18258416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.schres.2007.12.487
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы